MedTrace Logo

Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1

NCT02147210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-03-07

No results posted yet for this study

Summary

The principal purpose is the study of the regulation of the expression of ephrin-B1 by immunofluorescence in kidney biopsies of patients with Chronic transplant glomerulopathy (CTG) compared to biopsies prior to the CTG, in same patients. Level of fluorescence in CTG biopsy will be the experimental reference value.

Conditions

  • Kidney Transplantation

Interventions

OTHER

biological analysis

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Céline Guilbeau-Frugier, MD · Service d'Anatomie Pathologique et Histologie-Cytologie,Rangueil Hospital, University Hospital of Toulouse

  • Jean-Michel Senard, Md PhD · Department of Pharmacology,Toulouse University Hospital and INSERM U1048

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147210 on ClinicalTrials.gov